J&J Page-Limit Flub Stifles Amgen Injunction, For Now

By Lauren Berg (March 2, 2023, 11:04 PM EST) — A Delaware federal judge on Thursday rejected Janssen Biotech’s bid to block Amgen from launching its own version of the blockbuster immunosuppressive product Stelara while the parties’ patent dispute plays out, saying the Johnson & Johnson subsidiary filed its overly long brief less than 10 minutes after asking the court’s permission….